MAIA Biotechnology Inc (AMEX:MAIA) has a beta value of 0.18 and has seen 0.98 million shares traded in the recent trading session. The company, currently valued at $58.01M, closed the recent trade at $2.29 per share which meant it gained $0.29 on the day or 14.50% during that session. The MAIA stock price is -161.57% off its 52-week high price of $5.99 and 62.88% above the 52-week low of $0.85. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.13 million shares traded. The 3-month trading volume is 120.34K shares.
MAIA Biotechnology Inc (AMEX:MAIA) trade information
Sporting 14.50% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the MAIA stock price touched $2.29 or saw a rise of 3.78%. Year-to-date, MAIA Biotechnology Inc shares have moved 95.73%, while the 5-day performance has seen it change 6.51%. Over the past 30 days, the shares of MAIA Biotechnology Inc (AMEX:MAIA) have changed 7.51%. Short interest in the company has seen 0.66 million shares shorted with days to cover at 10.99.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
MAIA Biotechnology Inc (MAIA) estimates and forecasts
Figures show that MAIA Biotechnology Inc shares have underperformed across the wider relevant industry. The company’s shares have lost -39.42% over the past 6 months, with this year growth rate of 12.75%, compared to 16.90% for the industry. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -25.01% over the past 5 years.
MAIA Dividends
MAIA Biotechnology Inc is expected to release its next earnings report in January this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
MAIA Biotechnology Inc (AMEX:MAIA)’s Major holders
Insiders own 17.49% of the company shares, while shares held by institutions stand at 7.51% with a share float percentage of 9.10%. Investors are also buoyed by the number of investors in a company, with MAIA Biotechnology Inc having a total of 20.0 institutions that hold shares in the company. The top two institutional holders are HALTER FERGUSON FINANCIAL INC. with over 0.72 million shares worth more than $2.47 million. As of 2024-06-30, HALTER FERGUSON FINANCIAL INC. held 4.1% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 0.54 million shares as of 2024-06-30. The firm’s total holdings are worth over $1.84 million and represent 3.051% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of Sep 30, 2024, the former fund manager holds about 1.59% shares in the company for having 401.59 shares of worth $0.9 million while later fund manager owns 153.38 shares of worth $0.35 million as of Sep 30, 2024, which makes it owner of about 0.61% of company’s outstanding stock.
